Schedule 13G ownership disclosure
AnaptysBio Inc
Common Stock · CUSIP: 032724106
Event date: 2024-12-31
- Filing-level shares
- 2,548,468
- Percent of class
- 8.4%
- BlackRock, Inc.
Shares: 2,548,468 · Class: 8.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002012383-25-001264
- Form type
- SCHEDULE 13G/A
- Filer
- ANAPTYSBIO, INC
- CIK
- CIK 1370053
- Filed
- Feb 05, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership